Zimmer Biomet Holdings Interest Expense 2011-2026 | ZBH

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Zimmer Biomet Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-31.1 M	-9.3 M	-128 M	12.2 M	23.8 M	-4.9 M	-15.6 M	-9.4 M	-66.5 M	-36.9 M	-46.7 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
23.8 M	-128 M	-28.4 M

Quarterly Interest Expense Zimmer Biomet Holdings

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.3 M	3.9 M	2.9 M	5.1 M	2 M	-100 K	3.8 M	-1.2 M	7.7 M	-	-25.4 M	-42.6 M	-56.1 M	-	300 K	8.1 M	7.7 M	-	10.6 M	3.8 M	3 M	-	-4.4 M	-4.7 M	-500 K	-	-2.2 M	-2.9 M	-3.6 M	-	-2.3 M	-1.7 M	-500 K	-	-1.1 M	-3.8 M	-3.8 M	-	4.3 M	-	-	-	-12.1 M	-	-	-	-	-	-	-	-	-	-	-	-11.7 M	-9.8 M	-11 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.6 M	-56.1 M	-3.86 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Viemed Healthcare VMD	252 K	$ 9.21	-0.11 %	$ 358 M	USA
Varex Imaging Corporation VREX	-4.4 M	$ 10.82	0.37 %	$ 448 M	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Abbott Laboratories ABT	548 M	$ 105.12	0.53 %	$ 183 B	USA
Vivos Therapeutics VVOS	-110 K	$ 1.12	-5.88 %	$ 5.62 M	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	-2.76 M	-	1.37 %	$ 20.5 M	USA
Align Technology ALGN	7.68 M	$ 165.94	-6.42 %	$ 12.4 B	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Beyond Air XAIR	9 K	$ 0.68	-1.74 %	$ 46 M	USA
Accuray Incorporated ARAY	559 K	$ 0.39	4.43 %	$ 40.1 M	USA
Alphatec Holdings ATEC	45.9 M	$ 11.05	-4.12 %	$ 1.66 B	USA
Xtant Medical Holdings XTNT	4.16 M	$ 0.57	0.5 %	$ 76.2 M	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	947 K	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Bruker Corporation BRKR	-38.2 M	$ 34.22	-3.17 %	$ 5.1 K	USA
Boston Scientific Corporation BSX	349 M	$ 69.21	-1.37 %	$ 102 B	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
CONMED Corporation CNMD	31.1 M	$ 35.63	-2.76 %	$ 1.11 B	USA
NanoVibronix NAOV	135 K	-	-	$ 1.08 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Aethlon Medical AEMD	10.1 K	$ 2.22	-2.2 %	$ 3.47 M	USA
Edwards Lifesciences Corporation EW	7.2 M	$ 79.12	-3.63 %	$ 46.3 B	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
AdaptHealth Corp. AHCO	-274 K	$ 11.15	-2.28 %	$ 1.51 B	USA
Penumbra PEN	893 K	$ 335.13	-0.38 %	$ 13 B	USA
OrthoPediatrics Corp. KIDS	6.05 M	$ 15.76	-3.64 %	$ 370 M	USA
LivaNova PLC LIVN	664 K	$ 61.5	-3.38 %	$ 3.35 B	Britain
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	99 K	-	10.0 %	$ 610 K	USA
Myomo MYO	-668 K	$ 0.68	0.43 %	$ 28.5 M	USA
Inspire Medical Systems INSP	-2.66 M	$ 49.39	-2.1 %	$ 1.45 B	USA
Pulmonx Corporation LUNG	790 K	$ 1.17	-5.65 %	$ 47.6 M	USA